Skip to main content
Login | Suomeksi | På svenska | In English

Browsing by Author "Mentula, Maarit"

Sort by: Order: Results:

  • Bosas, Janina; Toffol, Elena; Pohjoranta, Elina; Mentula, Maarit; Hurskainen, Ritva; Suhonen, Satu; Heikinheimo, Oskari (2023)
    Introduction Sexual well-being is associated with general well-being. Several factors, such as overweight, infertility, anxiety, and sex hormones, also play a role, but the effects of hormonal contraception remains a point of debate. We characterized the factors associated with sexual well-being in fertile-aged women following induced abortion. Methods A 5-year follow-up of a nested longitudinal cohort study examining the effects of routine provision of intrauterine contraception as part of abortion care. Sexual well-being, anxiety, and quality of life were assessed annually using validated questionnaires (McCoy Female Sexuality Questionnaire, State-Trait Anxiety Inventory and EuroQoL), along with data on general and reproductive health, and relationship status. Of the 742 women participating in the trial, 290 (39%) provided sufficient follow-up data and were included in this study. Results Based on trajectories of McCoy-scores across the 5-year follow up, two groups were identified: those with stable and higher (n=223, 76.9%) and those with declining sexual well-being (n=67, 23.1%). Women in the group of declining sexual well-being had significantly higher levels of anxiety and lower quality of life at all time points. They also had more often chronic diseases and were less happy in their relationships. No differences were found in method of contraception when classified as hormonal vs non- hormonal, or long-acting vs short-acting reversible contraception. Conclusions Lower anxiety and higher quality of life are associated with stable and higher sexual well- being. Method of contraception or relationship status are not associated with sexual well-being during long-term follow-up in fertile aged women.
  • Kuha, Laura; Korjamo, Riina; Heikinheimo, Oskari; Mentula, Maarit (2021)
    Introduction: Little is known concerning the optimal misoprostol loading dose following mifepristone pretreatment in late first trimester medical abortion. We examined the efficacy, total dose of misoprostol needed, length of hospital stay, need for analgesia, and complications of two misoprostol loading doses (400 vs. 800 mcg) in late first trimester medical abortion. Materials and methods: This retrospective sequential cohort study compared misoprostol loading doses of 400 mcg and 800 mcg among women requesting medical abortion at 9–12 weeks of gestation in Helsinki University Hospital, Finland. Results: Altogether, 413 women received the 400-mcg and 287 women the 800-mcg loading dose of misoprostol. The median fetal expulsion time was 357 minutes (IQR 285–475) following the 400-mcg and 311 minutes (210–419) following the 800-mcg loading dose (p<0.01). The median length of hospital stay was 515 min vs. 520 min (p = 0.79). The total amount of misoprostol administered was 1200 mcg vs.1600 mcg (p < 0.01), respectively. Fewer women in the 400-mcg misoprostol group needed analgesia using strong opioids (150 [36.5%] vs. 133 [46.3%], p < 0.01) than women in the 800-mcg misoprostol group. The need for surgical evacuation was lower in the 400-mcg than the 800-mcg group (51 [12.4%] vs. 53 [18.5%], p = 0.03). Conclusions: A misoprostol loading dose of 800 mcg associates with a shorter fetal expulsion time compared to a loading dose of 400 mcg. However, a higher loading dose increases the need for strong opioids and the risk of surgical evacuation.